Showing results (131-140 of 365) with videos related to
Sort By:
Pageof 37
Sleep|February 3, 2011
Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled studyTimothy A Roehrs, Surilla Randall, Erica Harris, et al.Sleep Health|October 27, 2017
Sleep maintenance difficulties in insomnia are associated with increased incidence of hypertensionPhilip Cheng, Vivek Pillai, Heather Mengel, et al.Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|October 9, 2015
Post Hoc Analysis of Data from Two Clinical Trials Evaluating the Minimal Clinically Important Change in International Restless Legs Syndrome Sum Score in Patients with Restless Legs Syndrome (Willis-Ekbom Disease)William G Ondo, Frank Grieger, Kimberly Moran, et al.Human Psychopharmacology|October 31, 2002
Dose-response effects of zaleplon as compared with triazolam (0.25 mg) and placebo in chronic primary insomniaChristopher L Drake, Timothy A Roehrs, Richard M Mangano, et al.Sleep|September 3, 2011
Sleep reactivity and insomnia: genetic and environmental influencesChristopher L Drake, Naomi P Friedman, Kenneth P Wright, et al.The American Journal of Managed Care|December 6, 2007
Patient identificationMichael J Thorpy, Joseph A Lieberman, Thomas Roth, et al.Sleep|March 4, 2014
Sleep loss, circadian mismatch, and abnormalities in reorienting of attention in night workers with shift work disorderValentina Gumenyuk, Ryan Howard, Thomas Roth, et al.Psychopharmacology|August 27, 2013
Lapses of attention as outcome measure of the on-the-road driving testJoris C Verster, Adriana C Bervoets, Suzanne de Klerk, et al.Nature and Science of Sleep|July 20, 2017
Total sleep time, alcohol consumption, and the duration and severity of alcohol hangoverMarith van Schrojenstein Lantman, Marlou Mackus, Thomas Roth, et al.The American Journal of Managed Care|December 6, 2007
Patient-management strategiesMichael J Thorpy, Joseph A Lieberman, Thomas Roth, et al.Pageof 37